From: Epstein–Barr virus, Cytomegalovirus, and Herpes Simplex-1/2 reactivations in critically ill patients with COVID-19
CMV
EBV
HSV-1
HSV-2
Reactivation (%)
61%
65%
48%
2.5%
Mortality among reactivated patients (%)
67%
64%
66%
100%
Media delay between ICU admission and DNAemia detection (days [IR])
8 [3–13]
4 [2–7]
5 [3–8]